Back in BMTI

[Goods]

BMTI got killed March 27th when JNJ's REGRANEX Gel product that uses the same active ingredient was said to increase cancer risks in diabetics.

The difference is, BMTI's product is for one time use during surgery and has virtually no risk IMO. Not that that matters to investors.

Even though the whole thing is way overblown Regranex will now have a warning label to appease the masses. That should play well for BMTI which still hasn't recovered completely from the drop. Had a nice pop on the news today but a 400 point drop can kill just about any momentum.

In @ 12.37

[Goods]

Got stopped out @ 11.91. Can't win em all.